Peer Review & Research Partnership.
We’re putting nine years of work out for scrutiny. If you can sharpen it, challenge it, or build on it — we want to hear from you.
Why we’re inviting review
Clinicians trust evidence they can examine. So rather than market around our data, we’re opening it to scrutiny. Our real-world findings are observational and uncontrolled — we say so plainly — and the right next step is independent eyes on the methods and controlled trials to test what the observational data suggests. That’s where you come in.
Who we’re inviting
MDs & DOs
Practicing physicians who want to pressure-test the clinical logic and outcome claims against their own experience.
GI & integrative clinicians
Specialists in gastroenterology, functional, and integrative medicine to review system-level resolution data.
Researchers & academics
Microbiome and biostatistics researchers to examine cohort definitions, methods, and analysis.
Co-investigators & IRB partners
Partners for the RCTs underway on The Regular One and The Bright One — including data-sharing and IRB collaboration.
What we’re asking
Read the methods
Request the full white paper and methods. Examine how cohorts were defined and how resolution was measured.
Scrutinize the work
Challenge the analysis, the limitations, and the conclusions. Tell us where it’s weak.
Collaborate
Join as a co-investigator, data-sharing partner, or IRB collaborator on the controlled trials in progress.
Trials underway
The Regular One
Randomized controlled trial in GI — moving the observational signal toward controlled evidence. Co-investigators welcome.
The Bright One
Randomized controlled trial in mood/neuro outcomes. Seeking data-sharing and IRB partners.
Request the methods. Partner with us.
Email us to request the full methods, become a peer reviewer, or open a research partnership. We read every note.
Email craig.rouskey@flore.com → Read the white paper →